Q4 2020 Aspira Women's Health Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to Aspira Womenâs Health Fourth Quarter 2020 Conference Call. My name is Laura, and I will be your coordinator for the call today. (Operator Instructions) As a reminder, this conference is being recorded.
Leading the call today are Valerie Palmieri, President and Chief Executive Officer; Bob Beechey, Chief Financial Officer; and Kaile Zagger, Chief Operating Officer; Dr. Lesley Northrop, Chief Scientific Officer; and Dr. Elena Ratner, Global Chief Medical Adviser and Clinical and Translational Medicine. After the prepared remarks, we will open the call for Q&A.
Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to Aspira's expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |